136 related articles for article (PubMed ID: 11735172)
1. Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma.
Lam P; Yuen AP; Ho CM; Ho WK; Wei WI
Eur J Surg Oncol; 2001 Dec; 27(8):750-3. PubMed ID: 11735172
[TBL] [Abstract][Full Text] [Related]
2. [A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
Tsukuda M; Ogasawara H; Kaneko S; Komiyama S; Horiuchi M; Inuyama Y; Uemura T; Uchida M; Kamata S; Okuda M
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1169-77. PubMed ID: 8031158
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
[TBL] [Abstract][Full Text] [Related]
5. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
[TBL] [Abstract][Full Text] [Related]
6. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
9. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
13. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
15. [Comparative clinical studies for head and neck cancer in Japan].
Fujii M
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935
[TBL] [Abstract][Full Text] [Related]
16. Management of nonsinonasal neuroendocrine carcinomas of the head and neck.
Barker JL; Glisson BS; Garden AS; El-Naggar AK; Morrison WH; Ang KK; Chao KS; Clayman G; Rosenthal DI
Cancer; 2003 Dec; 98(11):2322-8. PubMed ID: 14635065
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.
Zorat PL; Paccagnella A; Cavaniglia G; Loreggian L; Gava A; Mione CA; Boldrin F; Marchiori C; Lunghi F; Fede A; Bordin A; Da Mosto MC; Sileni VC; Orlando A; Jirillo A; Tomio L; Pappagallo GL; Ghi MG
J Natl Cancer Inst; 2004 Nov; 96(22):1714-7. PubMed ID: 15547184
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Sanghera P; McConkey C; Ho KF; Glaholm J; Hartley A
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1342-51. PubMed ID: 17241752
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
20. [Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer].
Toda K; Kishimoto M; Imura S; Ogasawara H; Hyo N; Kumoi T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2280-5. PubMed ID: 3111382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
